# Real Time Genomics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/real-time-genomics

- Industry: Software
- Headquarters: San Francisco, US
- Website: www.realtimegenomics.com
- Total disclosed funding: $3M
- Latest round: Series A (Feb 19, 2009)
- Investors on record: 1

## About

Real Time Genomics Inc. provides bioinformatics services and analytical solutions aimed at efficiently extracting insights from genomic data to support research and development in biotechnology and healthcare.Founded in 2004, Real Time Genomics Inc. is headquartered in San Francisco, US. The company specializes in bioinformatics and has pivoted its focus to providing tailored genomic data solutions across international markets. In May 2013, Real Time Genomics raised USD 1.84 mn in Series A funding, which is the total amount raised to date, from unspecified investors. The company has executed two deals.Real Time Genomics (RTG) specializes in bioinformatic services and analytical solutions designed to streamline the extraction of knowledge from raw genomic data. Their core offerings include a robust bioinformatic Information Technology platform, hosting services for servers, storage, and networking, alongside tool-agnostic bioinformatic services. These services are tailored to address complex challenges faced by clients in both New Zealand and international markets, catering to a diverse clientele that encompasses research institutions, biotechnology firms, and healthcare organizations. The solutions provided by RTG are particularly valuable in advancing genomic research and developing intellectual property, enabling clients to tackle their most difficult problems with precision and efficiency.The revenue model of Real Time Genomics is primarily structured around the provision of bioinformatic services and analytical solutions, which are delivered through contractual partnerships with various clients. The company engages in business-to-business transactions, offering subscription-based access to their technological platform and consulting services to research and biotech firms. Clients may enter into agreements that involve customized service packages, reflecting the specific needs and complexities of their genomic projects. These agreements facilitate ongoing collaborations, potentially incorporating long-term partnerships that enhance mutual growth. Specific pricing details for their services are structured to reflect the depth and scope of the analytical solutions provided, aligning costs with the client’s research objectives and project requirements.Real Time Genomics plans to leverage its recent funding of USD 1.84 mn raised in May 2013 to develop new products and enhance its existing bioinformatics platform. They aim to expand into new markets, targeting additional regions in Europe and Asia by 2025, to better serve their growing international client base. The funding will support the development of innovative tools and solutions to meet the evolving needs of the biotech and healthcare sectors.

## Funding rounds

- Series A, Feb 19, 2009, $3M — Catamount Ventures

## Investors

- Catamount Ventures (https://capitalatlas.ai/funds/catamount-ventures) — Series A